Effekt af statiner på koronar endothelfunktion hos HIV-positive i antiretroviral behandling - HIV-Stati
- Conditions
- HIV-positiv i antiretroviral behandling
- Registration Number
- EUCTR2005-003184-23-DK
- Lead Sponsor
- Klinik for Klinisk Fysiologi, Nuklearmedicin og PET, Rigshospitalet
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
•Verificeret HIV
•I antiretroviral behandling (min 3 år)
•Alder < 60 år
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
•Alkohol misbrug.
•Alder < 18 år.
•Graviditet, laktation.
•Kendt iskæmisk hjertesygdom
•Diabetes mellitus
•Kolesterolsænkende behandling
•Klaustrofobi
•Leversygdom
•Nedsat nyrefunktion
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: At undersøge effekten af statiner på den globale myokardieperfusionsreserve (koronar endothelfunktion) hos hyperkolesterolæmiske og normokolesterolæmiske HIV-positive i antiretroviral behandling ved hjælp af PET og perifer endothelfunktion;Secondary Objective: ;Primary end point(s): PET-estimeret myokardieperfusionsreserve
- Secondary Outcome Measures
Name Time Method